|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Healthy | |||||
| 2 | Interventions listed in this trial | ||||
| Pioglitazone HCl Tablets 45 mg | |||||
| Actos® Tablets 45 mg | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Pioglitazone | |||||
| 4 | More general drug interventions related to this trial | ||||
| Hypoglycemic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 5 | Sponsors listed in this trial | ||||
| Mylan Pharmaceuticals | |||||